Le Lézard
Classified in: Health, Science and technology
Subject: PLW

FastWave Medical Extends Intellectual Property Portfolio with the Issuance of its Utility Patent for Novel Laser-IVL Technology


Fast-moving medical device startup continues to fortify its intellectual property protection with the company's latest patent for a novel laser-IVL system from USPTO.

MINNEAPOLIS, April 16, 2024 /PRNewswire-PRWeb/ -- FastWave Medical, a pre-revenue medical device company developing advanced intravascular lithotripsy (IVL) technology, proudly announces the issuance of its fourth utility patent by the United States Patent and Trademark Office (USPTO). This significant milestone further strengthens the company's intellectual property foundation to advance its next-generation laser-IVL platform. This innovative technology is designed to provide physicians with more options to effectively treat calcific artery disease, offering durable and fast energy delivery, enhanced sonic output, and a high-performing catheter to navigate complex arterial anatomy.

"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy.

Dr. William Nicholson, Director of Interventional Cardiology at Emory Healthcare, Associate Professor at Emory University School of Medicine, and one of FastWave Medical's physician advisors, expressed his excitement about the potential for the company's laser-IVL system, stating, "FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy. It also enables FastWave's team of engineers to develop an ultra-sleek balloon catheter, overcoming the challenges of existing IVL options in reaching and crossing diseased vessels."

Millions of people worldwide have occlusive arterial disease that is further complicated by the presence of calcium, leading to increased morbidity and mortality. FastWave's differentiated laser-IVL system aims to address hurdles associated with treating calcified arteries. Through its advanced lithotripsy technology, FastWave aims to solve the gaps with current IVL solutions while improving ease of use and patient safety by reducing procedural complications.

"It's a very exciting time for FastWave and the field of IVL to further enable physicians to optimize procedural outcomes for their patients," said co-founder and CEO of FastWave Medical, Scott Nelson. "Our growing IP portfolio is a key asset and catalyst to advance IVL technology with novel energy sources and design elements that can expand its use for more patients. I am excited and proud of the FastWave team for their dedication to power innovation that enhances clinical outcomes."

About FastWave Medical Inc.

FastWave Medical is at the forefront of developing intravascular lithotripsy (IVL) systems for calcific artery disease. With an emphasis on empowering physicians with procedural efficiency, FastWave aspires to redefine the sector by introducing next-generation IVL technologies that elevate the clinician experience and overall patient care. For more insights, please visit https://fastwavemedical.com.

Media Contact
FastWave Medical
(833) 888-9283
[email protected]

Media Contact

Media Relations, FastWave Medical, 1 (833) 888-9283, [email protected], https://fastwavemedical.com 

SOURCE FastWave Medical


These press releases may also interest you

at 14:08
Life Time Appoints James LaValle Chief Science Officer
Life Time today announced the appointment of James LaValle, clinical pharmacist, C.C.N.M.T. as Chief Science Officer. LaValle will spearhead the development and implementation of scientific initiatives and strategic relationships to support MIORA,...

at 14:01
Stratus® Medical announces continued expansion of its intellectual property coverage in Europe with additions to its global patent portfolio for the NIMBUS® Electrosurgical RF Multitined Expandable Electrode and registration of a Community design for new platform technology in development
Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency (RF) technology for the treatment of pain, announced today the expansion of patent protection in Europe for its NIMBUS®...

at 13:50
Newborn Screening Emergency: Urgent Call for Action to Identify 10,000+ Undiagnosed Rare Diseases
The push for a transformative U.S.-India partnership in newborn screening (NBS) sets the stage for a seismic shift in tackling rare diseases, spotlighting the need to prepare for the digital AI revolution in global healthcare. Advocates are rallying...

at 13:39
FDA to Hold Listening Session as Part of Broader Work to Optimize Use of, and Processes for, Advisory Committees
Today, the U.S. Food and Drug Administration announced it will host a listening session in June as part of its broader work to optimize the use of, and processes for, advisory committees. This virtual public meeting will focus on the composition of...

at 13:35
Health-E Commerce® shares 5 ways to use FSA or HSA funds to support women's health
The hormonal changes that women experience throughout their lives put them at increased risk for serious or chronic health conditions like diabetes, stroke, obesity, and even breast cancer. Fortunately, managing...

at 13:31
CHOP Study Finds Healthcare Providers Play Crucial Role in Guiding Autistic Adolescents and Their Families into Adulthood
Healthcare providers are a vital resource for autistic adolescents and their families as they prepare for the transition to adulthood, which may include learning to drive, according to a new study from researchers at Children's Hospital of...

More news about Health...


News published on and distributed by: